A clinical trial to compare varying duration of phototherapy for treatment of jaundice in premature infants.
Phase 3
- Conditions
- Health Condition 1: P073- Preterm [premature] newborn [other]
- Registration Number
- CTRI/2023/11/059784
- Lead Sponsor
- Surya Childrens Medicare Pvt. Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Preterm infant born at Gestational age 29+0 to 33+6 weeks and indicated for phototherapy in the first 14 days of postnatal life.
Exclusion Criteria
1.Serious congenital anomaly,
2.Infant with Rh or ABO isoimmunisation. (Direct coombs test Positive)
3.Infant with G6PD deficiency.
4.Infants requiring phototherapy after 14 days of postnatal age.
5.Out born infant with phototherapy initiated prior to admission.
6.Infant birth weight <900grams.
7.Severe hyperbilirubinemia at first screening (TSB within 1-1.5 mg/dl of the exchange transfusion cut-off for gestational age.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method